维普期刊资源整合服务平台（V6.5）

39篇 您的检索式：作者名="CALABRESI PA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Natalizumab re- duces visual loss in patients with relapsing multiple sclerosis 显示文摘	Baiter LJ Galetta SL Calabresi PA	2007	Neurology2007，68，16：	1
2	The inci- dence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL显示文摘	Calabresi PA Giovannoni G Confavreux C	2007	Neurology2007，69，14：	1
3	Natalizumab plus interferon beta-1a for relapsing multiple sclerosis显示文摘	Rudick RA Stuart WH Calabresi PA		0，，：	1
4	Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI显示文摘	STONE LA BASH CN	1997	Neurology1997，48，5：	1
5	The utility of MRI in suspected MS:report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology显示文摘	Frohman EM Goodin DS Calabresi PA		0，，：	1
6	Natalizumab plus interferon beta-1 a for relapsing multiple sclerosis 显示文摘	RUDICK RA STUART WH CALABRESI PA	2006	N Engl J Med2006，354，9：	1
7	Clay-shoveler's fracture during indoor rock climbing显示文摘	Kaloostian PE Kim JE Calabresi PA	2013	Orthopedics2013，36，3：	1
8	Natalizumab plus interferon beta-1a for relapsing multiple sclerosis显示文摘	Rudick RA Stuart WH Calabresi PA	2006	N Engl J Med2006，354，9：	1
9	Automated vs conven- tional tractography in multiple sclerosis: variability and correlation with disability 显示文摘	Reich DS Ozturk A Calabresi PA	2010	Neuroimage2010，49，4：	1
10	Rituximab in re-lapsing-remitting multiple sclerosis:a 72-week,open-label,phaseⅠtrial显示文摘	Bar-Or A Calabresi PA Arnold D	2008	Ann Neurol2008，63，3：	1
11	The incidence and significance of anti-natalizumab antibodies:results from AFFIRM and SENTINEL显示文摘	Calabresi PA Giovannoni G Confavreux C	2007	Neurology2007，69，14：	1
12	Natalizumab plus interferon beta-1a for relapsing multiple sclerosis显示文摘	Rudick RA Stuart WH Calabresi PA	2006	N Engl J Med2006，354，9：	1
13	The utility of MRI in suspected MS:Report of the therapeutics and teehnol-ogy Assessment Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurolo gy Society显示文摘	Frohman EM Goodin DS Calabresi PA	2003	Neurology2003，61，5：	1
14	Natalizumab reduces visual loss in patients with relapsing multiple sclerosis显示文摘	Balcer LJ Galetta SL Calabresi PA	2007	Neurology2007，68，16：	1
15	Natalizumab reduces visual loss in patients with relapsing multiple sclerosis 显示文摘	Baicer LJ Galetta SL Calabresi PA	2007	Neurology2007，68，16：	1
16	The utility of MRI in suspected MS:Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology显示文摘	Frohman EM Goodin DS Calabresi PA	2003	Neurology2003，61，：	1
17	Natalizumab reduces visual loss in patients with relapsing multiple sclerosis 显示文摘	Balcer LJ Galetla SL Calabresi PA	2007	Neurolgy2007，68，16：	1
18	Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells显示文摘	GRISHKAN IV NTRANOS A CALABRESI PA	2013	Cell Immunol2013，284，12：	1
19	显示文摘	Calabresi PA Prat A Biermacki K	2001	J Neuroimmunol2001，115，12：	1
20	The ef- ficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL 显示文摘	HUTCHINSON M KAPPOS L CALABRESI PA	2009	J Neurol2009，256，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示